Biggest News Aggregation in the World
📰 Conference Session News

Conference Session News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Conference Session. Real-time updates on events, politics, business and more.

Protagonist Therapeutics Announces Oral Presentation on Long-Term Follow-up of Rusfertide Phase 2 RE

NEWARK, CA / ACCESSWIRE / May 14, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that additional data from the rusfertide Phase 2 REVIVE open label extension study will be the focus of an oral presentation at the European Hematology Associatio...
Ann Arbor United States Hall Goya Kristenm Pettit Corey Davis Division Of Hematology Oncology

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science